Filing Analysis
Caring Brands, Inc. entered into a $11 million Securities Purchase Agreement to issue Series B Convertible Preferred Stock and a significant number of warrants to accredited investors. The deal includes highly dilutive terms, including full-ratchet anti-dilution protection and a 19.99% exchange cap requiring shareholder approval.
🚩 Red Flags
- Highly dilutive warrant structure (up to 22 million total shares issuable).
- Full-ratchet anti-dilution protection in warrants.
- Significant potential dilution via 8% cumulative dividend on preferred stock.
- Requirement for shareholder approval to bypass the 19.99% exchange cap.
- Liquidated damages clause in the Registration Rights Agreement (1.0% per month).
- Restrictions on the company's ability to perform reverse stock splits or equity lines of credit.
📋 Key Facts
- Total gross proceeds from the Series B offering: up to $11,000,000.
- Issuance of up to 11,000 shares of Series B Convertible Preferred Stock at $1,000 per share.
- Issuance of Series A Warrants to purchase 11,000,000 common shares at $0.825/share.
- Issuance of Series B Warrants to purchase 11,000,000 common shares at $0.95/share.
- Series B Preferred Stock carries an 8% annual dividend (cash or stock).
- Warrants contain full-ratchet anti-dilution protection.
- The offering includes an 'Exchange Cap' limiting conversion/exercise to 19.99% of outstanding shares without shareholder approval.
- The company is prohibited from entering into variable rate transactions or reverse stock splits for 120 days following registration statement effectiveness without investor consent.
Caring Brands, Inc. issued an 8-K to provide a press release update regarding its United States patent portfolio for the Hair Enzyme Booster and Photocil product platforms.
📋 Key Facts
- The filing is an Item 8.01 (Other Events) report dated August 6, 2026.
- The company provided updates concerning its US patent portfolio.
- Specific products mentioned include 'Hair Enzyme Booster' and 'Photocil' product platforms.
Caring Brands, Inc. received a Staff Delisting Determination from Nasdaq after failing to satisfy continued listing standards regarding stockholders' equity and alternative compliance metrics. The company is appealing the decision via a hearing request to avoid immediate trading suspension.
🚩 Red Flags
- Delisting notice (Nasdaq Rule 5550(b) non-compliance)
- Inability to secure definitive financing agreements despite previous compliance plans
- Low stockholders' equity ($2.09M vs $2.5M requirement)
- Imminent trading suspension scheduled for July 24, 2026
📋 Key Facts
- Company reported stockholders' equity of $2,091,324, which is below the Nasdaq requirement of $2.5 million.
- The company failed alternative listing standards: market value of listed securities < $35M and net income requirements not met.
- Nasdaq Staff denied a compliance plan because the company had not secured definitive agreements for additional financing from its Series A PIPE investor.
- Trading suspension is scheduled for July 24, 2026, unless a hearing request is filed by July 22, 2026.
- The company intends to submit a hearing request by July 21, 2026, which will stay the suspension pending a decision.
Caring Brands, Inc. completed a $400,000 PIPE offering of Series A Convertible Preferred Stock and warrants to an accredited investor. Notably, $150,000 of the proceeds are earmarked to redeem shares held by the Company's Chairman/CFO.
🚩 Red Flags
- Related-party transaction: $150,000 of new capital is being used to buy out shares from the Company's Chairman and acting CFO.
- Highly dilutive terms: Conversion price ($0.40) and warrant exercise price ($0.40) are likely significantly below current market value (implied by the $950/share purchase price vs $1,000 stated value structure).
- Death spiral potential: The combination of low-priced conversion rights and warrants often leads to significant downward pressure on the stock price.
- Small offering size ($400k) relative to typical micro-cap operations suggests urgent need for liquidity.
📋 Key Facts
- Completed a PIPE offering on July 10, 2026, for approximately $400,000 in gross proceeds.
- Issued 443.213 Series A Convertible Preferred Shares at a purchase price of $950 per share (after a 5% OID).
- Conversion price for preferred stock is set at $0.40 per share.
- Issued 1,052,632 warrants with an exercise price of $0.40 per share, exercisable immediately and expiring in five years.
- The company will use $150,000 to redeem 150,000 shares from BK Investments LLC (owned by Chairman/CFO Brian John).
- Series A Preferred Stock carries an 8% dividend rate.
Caring Brands, Inc. held a Special Meeting of Stockholders on July 9, 2026, where shareholders approved three major proposals including an additional investment right and the issuance of new shares. The approval to increase authorized common stock suggests imminent dilution or capital raising activity.
🚩 Red Flags
- Approval of share issuance and increased authorized shares typically signals significant upcoming dilution for existing shareholders.
- The 'Additional Investment Right' often implies a private placement or structured financing that may be dilutive to retail investors.
📋 Key Facts
- Special Meeting held on July 9, 2026.
- Quorum was established with 5,617,697 shares (approx. 61.79% of outstanding shares) present/represented.
- Proposal 1: Approval of the Additional Investment Right Proposal was approved.
- Proposal 2: Approval of the Share Issuance Proposal was approved.
- Proposal 3: Approval of the Increase in the Number of Authorized Shares of Common Stock was approved.
Caring Brands, Inc. filed a current report to disclose the issuance of a press release on June 1, 2026. The filing serves as a formal record of the announcement but contains no substantive financial or operational data within the text of the 8-K itself.
📋 Key Facts
- The company issued a press release on June 1, 2026.
- The press release is attached as Exhibit 99.1.
- The filing was signed by CEO Dr. Glynn Wilson.
Caring Brands, Inc. filed an 8-K to correct a clerical error in its Definitive Proxy Statement filed on May 12, 2026. The company is correcting the record date for the annual meeting of stockholders from May 12, 2026, to May 14, 2026.
📋 Key Facts
- The filing corrects an 'inadvertent error' regarding the record date for the annual meeting of stockholders.
- The previously stated record date was May 12, 2026.
- The correct record date is May 14, 2026.
- The company intends to file a revised definitive proxy statement to reflect this change.
Caring Brands, Inc. received a notice from Nasdaq on April 7, 2026, indicating non-compliance with the minimum stockholders' equity requirement of $2.5 million. The company reported stockholders' equity of $2,091,324 in its 10-K for the year ended December 31, 2025, and must submit a compliance plan by May 22, 2026.
🚩 Red Flags
- Stockholders' equity is approximately 16% below the required $2.5 million threshold.
- Failure to meet any of the three alternative Nasdaq listing criteria (equity, market value, or net income).
- Potential delisting from The Nasdaq Capital Market if the compliance plan is not accepted or executed.
📋 Key Facts
- Received Nasdaq Staff Delisting Determination letter on April 7, 2026.
- Non-compliant with Nasdaq Listing Rule 5550(b)(1) requiring $2.5 million in stockholders' equity.
- Reported stockholders' equity was $2,091,324 as of December 31, 2025.
- Failed to meet alternative standards: $35 million market value of listed securities or $500,000 net income.
- Deadline to submit a compliance plan is May 22, 2026.
- If the plan is accepted, Nasdaq may grant an extension until October 4, 2026, to regain compliance.
Caring Brands, Inc. reduced its shareholder quorum requirement from a majority to 33 1/3% and appointed its Chairman/CIO, Brian John, as Interim CFO. These moves consolidate control and lower the threshold for passing corporate resolutions.
🚩 Red Flags
- Reduction of quorum requirement to 33 1/3% allows a minority of shareholders to make significant corporate decisions.
- Concentration of power: The Chairman of the Board and Chief Investment Officer is now also the Interim CFO and Principal Financial Officer.
- Multiple 8-K items (3.03, 5.02, 5.03) filed simultaneously regarding governance and management changes.
📋 Key Facts
- Bylaw amendment adopted on March 29, 2026, reducing the quorum for stockholder meetings to 33 1/3% of outstanding shares.
- Brian John, the Company's Chairman and Chief Investment Officer, was appointed Interim CFO, Principal Financial Officer, and Principal Accounting Officer effective March 30, 2026.
- The quorum change was justified by the company as a means to 'improve the Company’s ability to hold shareholder meetings when called.'
- Brian John is the founder of the company and has previously served as CEO of Safety Shot (NASDAQ: SHOT) and SRM Entertainment (NASDAQ: SRM).
- No material changes to Mr. John's compensation were made in connection with the interim appointment.
Caring Brands, Inc. closed a $3.6 million PIPE offering of Series A Convertible Preferred Stock and warrants, primarily to fund the redemption of 6.25 million shares from company insiders. Approximately 85% of the proceeds ($3.075 million) will be used to cash out the CEO, Chairman, and a related entity, NovoDX, Inc.
🚩 Red Flags
- Significant related-party transaction: 85% of capital raised is being used to cash out the CEO and Chairman.
- Toxic financing features: The Additional Investment Right (AIR) allows for pricing at 90% of the lowest trading prices over a 10-day period.
- Original Issue Discount (OID) of 5% on the preferred stock purchase price.
- Warrants include a Black-Scholes cash-out provision in the event of fundamental transactions.
- Right of first refusal granted to the purchaser for all future equity or debt offerings for 12 months.
📋 Key Facts
- Entered into a Securities Purchase Agreement on March 19, 2026, for a $3.6 million PIPE offering.
- Issued 3,789.74 shares of Series A Convertible Preferred Stock with a 5% Original Issue Discount (OID) and a $1,000 stated value.
- Series A Preferred Stock is convertible at $0.40 per share and carries an 8% dividend.
- Issued 9,473,685 common warrants with an exercise price of $0.40 and a five-year term.
- Redeemed 6,250,000 common shares for $3.075 million from CEO Dr. Glynn Wilson (1.5M shares), Chairman Brnan John (1.25M shares), and NovoDX, Inc. (3.5M shares).
- Common stock outstanding reduced from 14,761,925 to 8,511,925 shares following the redemption.
- Purchaser granted an Additional Investment Right (AIR) for up to $4.0 million with a 'death spiral' pricing floor (90% of the 5-day low).
Caring Brands, Inc. announced the issuance of two new U.S. patents related to its proprietary hair follicle enzymatic activity technology. This filing serves to update investors on the expansion of the company's intellectual property portfolio.
📋 Key Facts
- Issued two new United States patents on January 2, 2026.
- Patents cover proprietary methods and compositions designed to enhance enzymatic activity in hair follicles.
- The IP supports the company's 'Hair Enzyme Booster' product line.
Caring Brands, Inc. announced the resignation of its Chief Financial Officer, Tyler Moore, effective January 5, 2026. The company stated the departure was not due to any disagreements regarding operations, policies, or practices.
🚩 Red Flags
- Sudden departure of a key executive (CFO) can create temporary administrative/reporting gaps during the transition period.
📋 Key Facts
- Tyler Moore resigned as CFO on January 5, 2026.
- The resignation is reportedly not related to any disagreement with the Company's operations, policies, or practices.
- The company has commenced a search for a successor and expects an appointment in the near term.
- Existing management will handle financial and reporting functions in the interim.
Caring Brands, Inc. entered into an exclusive worldwide license agreement with Itonis Pharmaceuticals on December 31, 2025, to manufacture and sell the homeopathic product 'Emesyl'. The deal involves a royalty structure and potential equity issuance based on sales milestones.
🚩 Red Flags
- Performance-based equity issuance (7% of Itonis's equity) could lead to significant dilution or complex cap table structures.
- Termination clause based on low sales thresholds ($25,000/quarter) poses a risk to the longevity of the asset.
📋 Key Facts
- Agreement date: December 31, 2025.
- License type: Exclusive, worldwide license for Emesyl and Emesyl Plus products.
- Royalty rate: 8% of Net Sales, payable quarterly.
- Equity milestone: Company entitled to receive 7% of Itonis's equity for every $200,000 in Product sales reached.
- Termination clause: Exclusive rights terminate if sales are $€25,000 or less for four consecutive quarters following product launch.
Caring Brands, Inc. completed a firm commitment public offering of 1,000,000 shares at $4.00 per share, generating approximately $3.23 million in net proceeds. The offering was conducted via D. Boral Capital LLC and included an over-allotment option and the issuance of warrants to the underwriter.
🚩 Red Flags
- Issuance of warrants to underwriter (potential future dilution).
- Significant lock-up period (180 days) may limit immediate liquidity for insiders but is standard for IPOs.
- Small net proceeds ($3.23M) relative to the scale of a public offering, suggesting limited runway.
📋 Key Facts
- Offered 1,000,000 shares of common stock at $4.00 per share.
- Gross proceeds: approximately $4.00 million; Net proceeds: approximately $3.23 million.
- Underwriter (D. Boral Capital LLC) received a warrant to purchase up to 30,000 shares (plus ~4,500 if over-allotment is exercised).
- The Underwriter Warrant has a 5-year term expiring November 14, 2030.
- Lock-up period of 180 days for the company, officers, directors, and 10% holders on shares issued/held.